SS
ANAB icon

Steve Schonfeld’s AnaptysBio ANAB Stock Holding History

Steve Schonfeld’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,431
Closed -$1.18M – 2186
2025
Q4 		$1.18M Buy
+24,431
New +$952K 0.01% 1062
2024
Q4 		– Sell
-6,351
Closed -$213K – 1980
2024
Q3 		$213K Sell
6,351
-165,242
-96% -$5.64M ﹤0.01% 1794
2024
Q2 		$4.3M Buy
+171,593
New +$4M 0.03% 603
2022
Q4 		– Sell
-25,465
Closed -$650K – 2568
2022
Q3 		$650K Buy
+25,465
New +$597K 0.01% 1562
2019
Q2 		– Sell
-91,600
Closed -$6.69M – 974
2019
Q1 		$6.69M Buy
91,600
+31,900
+53% +$2.2M 0.23% 118
2018
Q4 		$3.81M Buy
59,700
+20,000
+50% +$1.49M 0.15% 196
2018
Q3 		$3.96M Buy
39,700
+34,000
+596% +$2.82M 0.18% 166
2018
Q2 		$405K Sell
5,700
-1,275
-18% -$107K 0.02% 576
2018
Q1 		$726K Buy
+6,975
New +$786K 0.05% 395

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Steve Schonfeld's ANAB Position: Q1 2026 in Review

Steve Schonfeld sold out of AnaptysBio (ANAB) in Q1 2026, closing a stake of 24,431 shares — an estimated $1.18M sold.

Steve Schonfeld first reported a position in ANAB in Q1 2018 and held it in 9 quarters. The position peaked at $6.69M in Q1 2019. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Steve Schonfeld reported no remaining AnaptysBio position as of Q1 2026 after selling out during the quarter.
  • Steve Schonfeld sold 24,431 AnaptysBio shares in Q1 2026, an estimated $1.18M.
  • Steve Schonfeld first reported a position in AnaptysBio in Q1 2018 and held it in 9 quarters.
  • Steve Schonfeld's AnaptysBio position peaked at $6.69M in Q1 2019.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.